HALLE/SAALE, Germany, December 19, 2013 – Probiodrug AG (Probiodrug) announced today the decision to provide research funding to the laboratory of Cynthia Ann Lemere, Ph.D., in […]
HALLE/SAALE, Germany, December 3, 2013 – Probiodrug AG (Probiodrug) and researchers from the Paul Flechsig Institute for Brain Research, University of Leipzig, Germany published results in […]
HALLE/SAALE, Germany, October 21, 2013 – Probiodrug AG (Probiodrug) today announced that Dr Glund Konrad, the Company’s chief executive officer will be providing an update of […]
HALLE/SAALE, Germany, October 8, 2013 – Probiodrug AG (Probiodrug) today announced that Dr Konrad Glund, the Company’s chief executive officer, will be providing an update of […]
HALLE/SAALE, Germany, September 27, 2013 – Probiodrug AG (Probiodrug) today announced that Hendrik Liebers, the Company’s chief financial officer will be providing an update of corporate […]
HALLE/SAALE, Germany, September 18, 2013 – Probiodrug AG (Probiodrug) today announced that Dr Glund Konrad, the Company’s chief executive officer will be providing an update of […]
HALLE/SAALE, Germany, September 16, 2013 – Probiodrug AG (Probiodrug) today announced the transition of Professor Dr Hans-Ulrich Demuth from the position of Chief Scientific Officer, following […]
HALLE/SAALE, Germany, July 16, 2013 – Probiodrug AG (Probiodrug) today provided an update on PQ912, an inhibitor of glutaminyl cyclase (QC) in clinical development for the […]
HALLE/SAALE, Germany, July 8, 2013 – Probiodrug AG (Probiodrug) announced that it will be making two poster and two oral presentations at the upcoming Alzheimer’s Association […]